Aalst Pharma
Board
1 director, no change since 2024Director, permanent representative Pieter VERMEERSCH
since 01-10-2024
listed in the 2025 annual accounts, filed on 13-08-2026
Permanent representatives 1
Mandates through the years
3 names, the dashed line is todayBoardEarliermandate already running before its first mention
Mandates as a list
- PG Pharmaceuticals
- Director, from 01-10-2024 to date
- PHARMAFIN
- Director (not named in the articles), from 01-01-2009 to 22-10-2024
- Manager, until 28-12-2023
- Kristel DE LEENEER
- Manager, from 01-01-2009 to 28-12-2023
Control
Parent
Equity €66,282
Profit €81,699 in 2025 (loss €121,507 in 2024)
Checked score 70
100%
This company
Aalst Pharma
Equity €74,844
Profit €54,034 in 2025
Capital
- Contribution
- €18,592.01
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- PG Pharmaceuticals
- PHARMAFIN
Source: parent in its own accounts, lists of holdings in the owners' accounts
Shareholders
2 ownersOwners 2
- PG PharmaceuticalsparentEquity €66,282 Profit of €81,699 in 2025 (loss of €121,507 in 2024) Checked score 70100%
- PHARMAFINparentEquity €899,335 Profit of €431,084 in 2024 (profit of €98,868 in 2023)100%